HCPCS Level IIdrugActive
J2353
Octreotide injection, depot
BETOS: O1E
Effective: 2004-01-01
Referenced in 3 policies
Description
Injection, octreotide, depot form for intramuscular injection, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Sandostatin Lar Depot
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
1 MG
Billing Units
10.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.